drugset / Trial / NCT02471833

Health Evaluation in African Americans Using RAS Therapy

NCT02471833

RandomizedParallel-groupDouble-blindPrevention

Summary

The purpose of this study is to determine if telmisartan, an FDA approved blood pressure medication, may also have beneficial effects on Alzheimer's disease prevention in African Americans, who are at high risk for Alzheimer's disease.

Timeline

Start
2015-04
Primary completion
2022-04-15
Completion
2022-04-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Telmisartan Other / unclassified 20 mg Oral
Subject Telmisartan Other / unclassified 40 mg Oral

Indications